Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections. [electronic resource]
Producer: 20170609Description: 710 p. digitalISSN:- 1471-2334
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Infective Agents, Urinary -- administration & dosage
- Cephalosporins -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Enterobacteriaceae Infections -- drug therapy
- Female
- Follow-Up Studies
- Humans
- Injections, Intravenous
- Levofloxacin -- administration & dosage
- Male
- Microbial Sensitivity Tests
- Middle Aged
- Penicillanic Acid -- administration & dosage
- Recurrence
- Tazobactam
- Treatment Outcome
- Urinary Tract Infections -- drug therapy
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.